A pharmacokinetic model for radioimmunotherapy delivered through cerebrospinal fluid for the treatment of leptomeningeal metastases.

@article{Lv2009APM,
  title={A pharmacokinetic model for radioimmunotherapy delivered through cerebrospinal fluid for the treatment of leptomeningeal metastases.},
  author={Yonggang Lv and Nai-Kong V Cheung and Bingmei M. Fu},
  journal={Journal of nuclear medicine : official publication, Society of Nuclear Medicine},
  year={2009},
  volume={50 8},
  pages={1324-31}
}
UNLABELLED Radioimmunotherapy can effectively treat leptomeningeal metastases when radiolabeled antibodies are administered into the cerebrospinal fluid (CSF). We developed a pharmacokinetic model to evaluate the role of kinetic and transport parameters of radioimmunotherapy in maximizing the therapeutic ratio, the ratio of the area under the curve for the concentration of the bound antibodies versus time (AUC[C(IAR)]), to that for unbound antibodies (AUC[C(IA)]). METHODS We simplified the… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-10 of 39 references

Textbook of Medical Physiology

  • AC Guyton, JE Hall
  • 10th ed. Philadelphia,
  • 2000
Highly Influential
4 Excerpts

Induction of tumor cell death by anti-GD2 monoclonal antibodies (MoAb): requirement of antibody Fc and a long residence time (slow koff) [abstract

  • H Xu, J Hu, NV. Cheung
  • J Clin Oncol. 2007;25(June
  • 2007
2 Excerpts

Similar Papers

Loading similar papers…